Abstract
Chronic critical limb ischemia (CLI) represents the most advanced form of atherosclerotic lower extremity vascular disease. By definition, the term characterizes patients with distal extremity perfusion so limited as to produce rest pain and/or tissue necrosis in the form of ischemic ulcers and gangrene. Clinically, patients with CLI differ from those with intermittent claudication (IC) by symptoms of ischemia present at rest as well as evidence of tissue breakdown or loss due to hypoperfusion. Acute limb ischemia (ALI), on the other hand, describes the patient in whom blood supply is suddenly interrupted, leading to sensory-motor symptoms and potential tissue destruction in short order if perfusion is not restored (see Chapter 7). ALI may occur in conjunction with CLI when a vessel with high-grade stenosis undergoes thrombosis or an embolus is superimposed on preexisting disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wahlenberg E, Lepner U, Olofsson P. Limb loss in association with vascular surgery: a five year series of major lower limb amputation. Eur J Vasc Surg 1994; 160: 561–567.
Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997; 26: 517–538.
Transatlantic Inter-Society Consensus (TASC) Working Group. Management of peripheral arterial disease (PAD). J Vasc Surg 2000;31:S5–S34, S54–S56, S176–188, S192–274, 5281–288.
Kempczinski RF. The chronically ischemic leg: An overview. In: Rutherford RB, ed. Vascular Surgery, 5th edit. Philadelphia: WB Saunders, 2000; pp. 917–927.
Lowe GD. Pathophysiology of critical limb ischemia. In: Dormandy J, Stock G, eds. Critical Limb Ischemia: Its Pathophysiology and Management. Berlin: Springer-Verlag, 1990; pp. 17–38.
Berliner JA, Navab M, Fogelman AM et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation and genetics. Circulation 1995; 91: 2488–2496.
Ross R. Cellular and molecular studies of atherosclerosis. Atherosclerosis 1997; 131: S3–4.
Dormandy J, Verstraete M, Andreani D, et al. Second European consensus document on chronic critical leg ischemia. Circulation 1991; 84 (Suppl 4): 1.
Dormandy J, Heeck L, Vig S. Predictors of early disease in the lower limbs. J Vasc Surg 1999; 12: 109–117.
Powel JT. Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med 1998; 3: 21–28.
Liedberg E, Perrson BM. Age, diabetes and smoking in lower limb amputation for arterial occlusive disease. Acta Orthop Scand 1983; 54: 383–388.
Murabito JM, D’Agostino RB, Silbershatz H, et al. Intermittent claudication: a risk profile from the Framingham heart study. Circulation 1997; 96: 44–49.
Celermajer DS, Sorenson KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88: 2149–2155.
DaSilva A, Widmer LK, Ziegler HW et al. The Basle longitudinal study; report on the relation of initial glucose level to baseline ECG abnormalities, peripheral artery disease, and subsequent mortality. J Chron Dis 1979; 32: 797–803.
Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995; 274: 1049–1057.
Martin MJ, Hulley SB, Browner WS, et al. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet 1986; 2: 933–936.
Blauw GJ, Lagaay AM, Smelt AH, et al. Stroke, statins and cholesterol: a meta-analysis of randomized, placebo-controlled, double blind trials with HMG-CoA reductase inhibitors. Stroke 1997; 28: 946–950.
Cheng SWK, Ting ACW, Wong J. Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease. Eur J Vasc Endovasc Surg 1997; 14: 17–23.
Hertzer NR, Beven EG, Young JR, et al. Coronary artery disease in peripheral vascular patients: a classification of 1000 coronary angiograms and results of surgical management. Ann Surg 1984; 199: 223–233.
Gentile AT, Taylor LM, Moneta GL, Porter JM. Prevalence of asymptomatic carotid artery stenosis in patients undergoing infrainguinal bypass surgery. Arch Surg 1995; 130: 900–904.
Alexandrova NA, Gibson WC, Norris JW et al. Carotid artery stenosis in peripheral vascular disease. J Vasc Surg 1996; 23: 645–649.
Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women less than 62 years of age. Am J Cardiology 1994; 74: 64–65.
Dormandy J, Heeck L, Vig S. The fate of patients with critical leg ischemia. J Vasc Surg 1999; 12: 142–147
Veith FJ, Gupta SK, Samson RH, et al. Progress in limb salvage by reconstructive arterial surgery combined with new or improved adjunctive procedures. Ann Surg 1981; 194: 386–401.
Hickey NC, Thompson IA, Shearman CP, et al. Aggressive arterial reconstruction for critical lower limb ischaemia. Br J Surg 1991; 78: 1476–1478.
Edwards JM, Taylor LM, Porter JM. Treatment of failed lower extremity bypass grafts with new autogenous vein bypass. J Vasc Surg 1990;11:132-
Coffman JD. Intermittent claudication: not so benign. Am Heart J 1986; 112: 1127–1128.
Catalano M. Epidemiology of critical limb ischemia. North Italian data. Eur J Med 1993; 2: 1–4.
The Vascular Surgical Society of Great Britain and Ireland: critical limb ischaemia: management and outcome. Report of a national survey. Eur J Vasc Endovasc Surg 1995;10:108–113.
Dormandy J, Heeck L, Vig S. Intermittent claudication: underrated risks. J Vasc Surg 1999; 12: 96–108.
Dormandy J, Heeck L, Vig S. Acute limb ischemia. J Vasc Surg 1999; 12: 148–53.
Stanley JC, Barnes RW, Ernst CB, et al. Work Force Issues Report of the Society for Vascular Surgery and the International Society for Cardiovascular Surgery, North American Chapter, Committee on Workforce Issues. J Vasc Surg 1996; 23: 172–181.
McDermott MM, Feinglass J, Slavensky R, Pierce WH. The ankle-brachial index as predictor of survival in patients with peripheral vascular disease. J Gen Intern Med 1994; 9: 445–449.
Newman AB, Shemanski L, Manolio T, et al. Ankle-arm index as predictor of cardiovascular disease and mortality in the cardiovascular health study. Arterioscler Thromb Vasc Biol 1999; 19: 538–545.
Hiatt WR, Hoag S, Hammen RE Effect of diagnostic criteria on the prevalence of peripheral arterial artery disease. Circulation 1995; 92: 1472–1479.
Rutherford RB, Lowenstein DH, Klein, ME Combining segmental arterial pressures and plethysmography to diagnose arterial disease in the legs. Am J Surg 1979; 38: 211–218.
Katz ML, Comerota AJ. Noninvasive evaluation of lower extremity arterial disease. In: Kerstein MD, White JV eds. Alternatives to Open Vascular Surgery. Philadelphia: JB Lippincott, 1995; pp. 215–224.
Cambria R, Kaufman JA, L’Italien, et al. Magnetic resonance angiography in the management of lower extremity arterial occlusive disease: a prospective study. J Vasc Surg 1997; 25: 380–389.
Baum RA, Rutter CM, Sunshine JH, et al. Multicenter trial to evaluate vascular magnetic resonance angiography of the lower extremity. American College of Radiology Rapid Technology Assessment Group. JAMA 1995; 274: 875–880.
Elsman BH. Impact of ultrasonographic duplex scanning on therapeutic decision making in lower limb arterial disease. Br J Surg 1995; 82: 630–633.
North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445–453.
Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273: 1421–1428.
Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001; 344: 1608–1621.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352: 837–853.
Gould AL, Rossouw JE, Santanello NC, et al. Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation 1998; 97: 946–952.
The sixth report of the joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413–2446.
Antiplatelet Trialists Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ (Clin Res Ed) 1988; 296: 320–331.
CAPRIE Steering Committee. A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329–1339.
deVries SO, Hunink MGM. Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis. J Vasc Surg 1997; 26: 558–569.
Brewster DC. Current controversies in the management of aortoiliac occlusive disease. J Vasc Surg 1997; 25: 365–379.
Nevelsteen A, Beyens G, Duchateau J, Suy R. Aorto-femoral reconstruction and sexual function: a prospective study. Eur J Vasc Surg 1990; 4: 247–251.
Bosch Jl, Hunink MGM. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997; 204: 87–96.
Tettero E, Haaring C, van der Graf Y, van Schaik JP, Van Engelen AD, Mali WP. Intraarterial pressure gradients after randomized angioplasty and stenting of iliac artery lesions. Dutch Iliac Stent Trial Group. Cardiovasc Intervent Radiol 1996; 19: 411–417.
Pomposelli FB, Marcaccio EJ, Gibbons GW, et al. Dorsalis pedis arterial bypass: durable limb salvage for foot ischemia in patients with diabetes mellitus. J Vasc Surg 1995; 21: 375–384.
Darling RC, Chang BB, Shah DM, Leather RP. Choice of peroneal or dorsalis pedis artery bypass for limb salvage. Semin Vasc Surg 1997; 10: 17–22.
Akbari CM, LoGerfo FW. Diabetes and peripheral vascular disease. J Vasc Surg 1999; 30: 373–384.
Kram HB, Gupta SK, Veith FJ, Wengerter KR, Panetta TF, Nwosis C. Late results of two hundred seventeen femoropopliteal bypasses to isolated popliteal artery segments. J Vasc Surg 1991; 14: 386–390.
Rutherford RB, Jones DN, Bergentz SE, et al. Factors affecting the patency of infrainguinal bypass. J Vasc Surg 1988; 8: 236–246.
Johnson WC, Lee KK and members of the Department of Veteran Affairs COOP Study 141. A comparative evaluation of polytetrafluoroethylene, umbilical vein and saphenous vein bypass grafts for femoral-popliteal above knee revascularization: a prospective, randomized Department of Veteran Affairs cooperative study. J Vasc Surg 2000; 32: 268–277.
Gentile AT, Lee RW, Moneta GL, Taylor LM, Edwards JM, Porter JM. Results of bypass to the popliteal and tibial arteries with alternate sources of autogenous vein. J Vasc Surg 1996; 23: 272–280.
Harris L, O’Brian-Irr M, Ricotta JJ. Long-term assessment of cryopreserved vein bypass grafting success. J Vasc Surg 2001; 33: 528–532.
Pappas PJ, Hobson RW, Meyers MG, et al. Patency of infrainguinal polytetrafluoroethylene bypass grafts with distal interposition vein cuffs. Cardiovasc Surg 1998; 6: 19–26.
Kreienberg PB, Darling RC III, Chang BB, et al. Adjunctive techniques to improve patency of distal prosthetic bypass grafts: polytetrafluoroethylene with remote arteriovenous fistulae versus vein cuffs. J Vasc Surg 2000; 31: 696–701.
Dardik H, Silvestri F, Alasio T, et al. Improved method to create the common ostium variant of the distal arteriovenous fistula for enhancing crural prosthetic bypass graft patency. J Vasc Surg 1996; 24: 240–248.
Kalman PG, Johnston KW, Walker PM. The current role of isolated profundaplasty. J Cardiovasc Surg 1990; 31: 107–110.
Tovar-Pardo AE, Bernhard VM. Where the profunda femoris fits in the spectrum of lower limb revascularization. Semin Vasc Surg 1995; 8: 225–235.
Bakal CW, Cynamon J, Sprayregen S. Infrapopliteal percutaneous transluminal angioplasty: what we know. Radiology 1996; 200; 36–43.
Parsons RE, Suggs WD, Lee JL, Sanchez LA, Lyon RT, Veith FJ. Percutaneous transluminal angioplasty for treatment of limb-threatening ischemia. J Vasc Surg 1998; 28: 1066–1071.
Antiplatelet Trialists’ Collaboration. Collaborative overview of randomized trials of antiplatelet therapy II: maintenance of vascular graft or arterial patency by antiplatelet therapy. Br Med J 1994; 308: 159–168.
Schomig A, Naumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 1996; 334: 1084–1089.
Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronoray stenting: the Full Anticoagulation versus Aspirin and Ticlopidine (FANTASTIC) study. Circulation 1998; 98: 1597–1603.
Rutherford RB, Jones DN, Bergentz SE, et al. The efficacy of dextran 40 in preventing early postoperative thrombosis following difficult lower extremity bypass. J Vasc Surg 1984; 1: 765–773.
Katz SG, Kohl RD. Does dextran 40 improve the patency of autogenous infrainguinal bypass grafts? J Vasc Surg 1998; 28: 23–26.
Persson AV, Anderson LA, Padberg FT. Selection of patients for lumbar sympathectomy. Surg Clin N An. 1985; 65: 393–403.
van Bemmelen PS, Mattos MA, Faught WE, et al. Augmentation of blood flow in limbs with occlusive arterial disease by intermittent calf compression. J Vasc Surg 1994; 19: 1052–1058.
Eze AR, Comerota AJ, Cisek PL, et al. Intermittent calf and foot compression increases lower extremity blood flow. Am J Surg 1996; 172: 130–134.
van Bemmelen PS, Weiss-Olmanni J, Ricotta JJ. Rapid intermittent compression increases skin circulation in chronically ischemic legs with infra-popliteal arterial obstruction. Vasa 2000; 29: 47–52.
Lundell A, Lindblad B, Berqvist D, Hansen E. Femoropopliteal—crural graft patency is improved by an intensive surveillance program: a prospective randomized study. J Vasc Surg 1995; 21: 26–33.
Nehler MR, Moneta GL, Yeager RA, Edwards JM, Taylor LM, Porter JM. Surgical treatment of threatened reversed infrainguinal vein grafts. J Vasc Surg 1994; 20: 558–563.
Kinney EV, Bandyk DF, Mewisson MW, et al. Monitoring functional patency of percutaneous trans-luminal angioplasty. Arch Surg 1991; 126: 743–747.
Vroegindewij D, Tielbeck AV, Buth S, van Kints MJ, Landman GH, Mali WE Recanalization of femoropopliteal occlusive lesions: a comparison of long term clinical, color duplex US, and arteriographic follow-up. JVIR 1995; 6: 331–337.
Dawson I, Hajo van Brockel J, Pesch-Batenburg J, et al. Late outcomes of limb loss after failed infrainguinal bypass. J Vasc Surg 1995; 21: 613–622.
Dormandy J, Belcher G, Broos P, et al. A prospective study of 713 below knee amputations for ischaemia and the effect of a prostacyclin analogue on healing. Br J Surg 1994; 81: 33–37.
Moore TJ, Barron J, Hutchinson F, Golden C, Ellis C, Humphries D. Prosthetic usage following major lower extremity amputation. Clin Orthop 1989; 238: 219–224.
Campbell WB, St. Johnston JA, Kernick VF, Rutter EA. Lower limb amputation: striking the balance. Ann R Coll Surg Engl 1994; 76: 205–209.
Comerota AJ, Throm RC, Miller KA, et al. Naked plasmid DNA encoding fibroblast growth factor type 1 (NV1FGF) for the treatment of end-stage unreconstructible lower extremity ischemia• preliminary results from a phase-1 trial. J Vasc Surg (accepted, 2002 ).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schmieder, F.A., Comerota, A.J. (2003). Chronic Critical Limb Ischemia. In: Coffman, J.D., Eberhardt, R.T. (eds) Peripheral Arterial Disease. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-331-6_6
Download citation
DOI: https://doi.org/10.1007/978-1-59259-331-6_6
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-326-8
Online ISBN: 978-1-59259-331-6
eBook Packages: Springer Book Archive